(Q36804749)

16 August 2017

1 reference

title

Cytotoxic suppression of acquired factor VIII:C inhibitors (English)

1 reference

16 August 2017

Green D

1

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 November 1991

1 reference

American Journal of Medicine

16 August 2017

published in

1 reference

16 August 2017

volume

91

1 reference

16 August 2017

issue

5A

1 reference

16 August 2017

page(s)

14S-19S

1 reference

Cyclophosphamide: Use in Practice

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980142-9

Cyclophosphamide: should it be used daily, monthly, or never?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980142-9

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980142-9

Factor VIII antibodies: immunosuppressive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980142-9

Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980142-9

Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980142-9

Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980142-9

Corticosteroid therapy for acquired F VIII:C inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980142-9

10.1016/S0002-9343(91)80142-9

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference